Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

3.01
Delayed Data
As of Mar 24
 -0.01 / -0.33%
Today’s Change
2.83
Today|||52-Week Range
9.02
-26.23%
Year-to-Date
Merrimack (MACK) Starts Enrollment in Solid Tumors Study
Mar 24 / Zacks.com - Paid Partner Content